Pre-earnings options volume in Aquestive Therapeutics (AQST) is normal with calls leading puts 10:3. Implied volatility suggests the market is anticipating a move near 7.1%, or 30c, after results are released. Median move over the past eight quarters is 5.0%.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AQST:
- AQST Upcoming Earnings Report: What to Expect?
- Aquestive Therapeutics assumed with an Outperform at Oppenheimer
- Investor Sue Aquestive Therapeutics Over ‘Postage Stamp’ Anaphylaxis Treatment Claims
- Aquestive Therapeutics Faces Investor Lawsuit Over Alleged Misleading Statements About Anaphylm FDA Approval Timeline
- Aquestive Advances Anaphylm NDA Resubmission After FDA Meeting